Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

The Company That’s Delivering Safe, Evidence-Based Psychedelic-Assisted Psychotherapies

Dave Jackson Dave Jackson, Stockhouse
4 Comments| October 14, 2020

{{labelSign}}  Favorites
{{errorMessage}}


(Click image to play podcast)
Listen on Apple PodcastsListen on Google Podcasts

Stockhouse investors who are dialed into the not-only nascent but now, pardon the pun, mushrooming psychedelics sector are likely familiar with a mental health and wellness company “centred on developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies.” In short, an entirely new way of successfully addressing and treating the growing prevalence of mental health issues and desire for greater wellness as a whole.

Numinus Wellness Inc. (NUMI) (TSX-V.NUMI, Forum) is a Company that is “creating an ecosystem of health solutions” aimed at advancing psychedelic laboratory testing, therapy, and research delivering psychedelic-assisted psychotherapies and other transformative and supportive health solutions. Also known as ‘magic mushrooms’, psilocybin and its assisted psychotherapy are currently being studied as a treatment for a wide range of mental health conditions including depression, anxiety, and substance use disorders.

The Company says its vertically-integrated ecosystem positions it to be a first-in-market, trusted leader in the delivery of psychedelic-assisted psychotherapies when regulated.

From product development and supply, to analytics and testing, to clinical protocol development and implementation science in partnership with leading research organizations, the unique ecosystem approach allows Numinus to ensure quality control and best-in-class delivery with steady revenue streams to support its developments.

In this lively and informative podcast, Stockhouse Media’s Dave Jackson reached out the Company Chairman & CEO Payton Nyquvest to discuss a myriad of timely and intriguing topics that investors need to know about this burgeoning market.

Click to download episode here.


FULL DISCLOSURE: This is a paid article produced by Stockhouse Publishing.


{{labelSign}}  Favorites
{{errorMessage}}

Comments

P.S. Dave - I am a investor in "Critical Elements Lithium Corporation" a well managed Explorer on the cusp of completing all the regulatory requirements before completing their high grade lithium mine (with nickel thrown in) Regards.
(55)
October 15, 2020

i.e. not shy about promoting powerful drugs to school children as a scam "Education aid et al"
(55)
October 15, 2020

.....use of "Acid". The freaks who promoted research (in so-called "Esteemed Universities in Canada and elsewhere) were and are not intending their revival for the societal well being. These drugs are powerfull and promoted by anti-social lunatics; many of their moronic devotees roam the halls of Parliament or Capital Buildings today. The "War on Drugs" was a sham now in the hands of the Powerful Medical Drug Industry not shy about promoting powerful drugs to school children as scam "Educational
(55)
October 15, 2020

Dave- Heads up. I survived Berkeley, Met Timothy Leary and Richard Alpert (aka RamDas) recently deceased) and concluded after seeing the wreckage from "Acid) literally zombies laying in doorways on Telegraph Avenue in Berkeley my personal research uncovered the source of the "pandrugemic" of the "60's. I suggest you read John D. Marks Book "In search of The Manchurian Candidate" and the "intelligence" source (Nazi connection et al) of the intended use of "Acid". The freaks who promoted researc
(55)
October 15, 2020

Leave a Comment

You must be logged in to be able to post a comment.

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today